Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention.
Williams
Mark A
MA
Fleg
Jerome L
JL
Ades
Philip A
PA
Chaitman
Bernard R
BR
Miller
Nancy Houston
NH
Mohiuddin
Syed M
SM
Ockene
Ira S
IS
Taylor
C Barr
CB
Wenger
Nanette K
NK
D000368:Aged; D000369:Aged, 80 and over; D000787:Angina Pectoris / Q000209:etiology; D001145:Arrhythmias, Cardiac / Q000209:etiology; D003327:Coronary Disease / Q000150:complications / Q000517:prevention & control* / Q000628:therapy; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000628:therapy; D019468:Disease Management; D015444:Exercise; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000628:therapy; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology; D009765:Obesity / Q000150:complications / Q000178:diet therapy; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors